Literature DB >> 8878320

Does minimizing neuroleptic dosage influence hyponatremia?

C M Canuso1, M B Goldman.   

Abstract

Neuroleptic dosage was reduced by 10% every 2 weeks in five male hyponatremic polydipsic patients with schizophrenia. Mean dose fell from 1980 +/- 1289 to 631 +/- 135 chlorpromazine equivalents/day over a mean of 12.2 weeks until behavioral relapse occurred. During this time, serum sodium did not vary from baseline levels (132.9 +/- 4.9 mEq/1), suggesting that minimizing neuroleptic dose does not alter the severity of hyponatremia in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878320     DOI: 10.1016/0165-1781(96)02793-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.

Authors:  Hideaki Tani; Shotaro Takasu; Hiroyuki Uchida; Takefumi Suzuki; Masaru Mimura; Hiroyoshi Takeuchi
Journal:  Neuropsychopharmacology       Date:  2019-11-26       Impact factor: 7.853

Review 2.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

3.  Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review.

Authors:  Faizan Mazhar; Vera Battini; Marco Pozzi; Elena Invernizzi; Giulia Mosini; Michele Gringeri; Annalisa Capuano; Cristina Scavone; Sonia Radice; Emilio Clementi; Carla Carnovale
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-14       Impact factor: 5.176

4.  A case report of rapid-onset hyponatremia induced by low-dose olanzapine.

Authors:  Sethulakshmi Sreevalsam Anil; Badr Ratnakaran; Nisha Suresh
Journal:  J Family Med Prim Care       Date:  2017 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.